Long-term survival in a patient with metastatic HER2+ breast cancer undergoing lapatinib-based therapy for 6 years

We report the case of a patient with HER2-positive breast cancer under adjuvant therapy (chemotherapy and trastuzumab) who developed a recurrence with bone (cervical spine) and lung involvement. After treatment with lapatinib and capecitabine, the patient remained stable with considerable improvemen...

Full description

Bibliographic Details
Main Authors: Salvatore Turano, Serafino Conforti
Format: Article
Language:English
Published: AboutScience Srl 2018-09-01
Series:AboutOpen
Subjects:
Online Access:https://journals.aboutscience.eu/index.php/aboutopen/article/view/7